Cytopathology proficiency testing: where do we go from here?
With the recent introduction of nationwide proficiency testing in cytopathology (PTC), reconsideration of several aspects of this controversial quality assurance method becomes justified. This paper discusses various merits and demerits of the PTC system currently prescribed by federal regulations, points out perceived deficiencies, and suggests methods for improvement.
Nagy
George K
GK
Cytopathology Laboratory, Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, New York 12201-0509, USA. gkn02@health.state.ny.us
Newton
Louise E
LE
D006801:Humans; D007753:Laboratories / Q000592:standards; D010338:Pathology, Clinical / Q000592:standards*; D011361:Professional Competence / Q000592:standards*; D011786:Quality Control